VB Shilpa offers contract development and manufacturing organization (CDMO) services, focusing on chemical development, high potent active pharmaceutical ingredients (API), peptide synthesis, and formulation development. It provides analytical support and has capabilities in biologics production.

VB Shilpa

Shilpa Medicare Limited, together with its subsidiaries, engages in the manufacturing and selling active pharmaceutical ingredients (API's), intermediates, and formulations in India, the United States, Europe, and internationally. It offers oncology and non-oncology API's.; and new drug delivery systems, peptides/biotech products, specialty chemicals, etc. The company also provides contract manufacturing of various dosage forms, such as tablets, capsules, liquid injections, lyophilized injectables, and sterile dry powder injectables. It is also involved in the wind power generation activities. Shilpa Medicare Limited was incorporated in 1987 and is headquartered in Raichur, India.

COM:VBSHILPA

VB Shilpa

Last Close

936.00

22/11 10:00

Market Cap

65.34B

Beta: -

Volume Today

943.27K

Avg: -

Analysis Not Available